GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Credit Losses Provision

Hemogenyx Pharmaceuticals (LSE:HEMO) Credit Losses Provision


View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Credit Losses Provision?

Credit Losses Provision only applies to banks.


Hemogenyx Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is clinical-stage biotechnology focused on the discovery, development and commercialisation of innovative treatments relating to the treatment of blood cancers, certain solid cancers, autoimmune diseases, and viral infections. The products under development are designed to address a range of problems that occur with current standard of care treatments.